Itraconazole Pellets (CAS NO : 84625-61-6)

Commercial and physical efficiency of our Itraconazole Pellets is the direct result of our complete, end-to-end integration across the molecular lifecycle. Itraconazole is characterised by extreme lipophilicity and a near-total lack of water solubility, creating severe absorption hurdles in the human gastrointestinal tract. By managing the value chain continuously - evolving from Key Starting Materials (KSMs) and core intermediates all the way to pre-finished formulations - we eliminate the manufacturing inconsistencies that plague open-market sourcing.

We bypass the traditional pitfalls of bulk crystalline APIs by using an advanced fluidized-bed solid-dispersion spray layering technology. The pure Itraconazole API is dissolved in an optimized solvent-polymer matrix and spray-layered over microcrystalline cellulose (MCC) or sugar spheres. This molecular dispersion breaks down the drug's natural crystalline lattice energy, locking it into an amorphous state that expands the active surface area exponentially. The active layer is then covered with a protective polymeric anti-tack layer to prevent particle agglomeration. This careful processing yields perfectly uniform, dust-free spheres that flow smoothly into capsule-filling machines, ensuring exact weight distribution, preventing local mucosal irritation, and maximizing drug release parameters.

Itraconazole's polymorphic profile is highly sensitive to processing conditions during ynthesis. If an API contains trace structural isomers or crystalline variations carried over from low-grade IT9 or IT7 intermediates, its solubility in the polymer spray matrix changes unpredictably. This variation alters the thermodynamic state of the amorphous solid dispersion on the pellet core, leading to slow dissolution and batch failure during regulatory biowaiver testing. Because we control the molecule's entire synthesis path, we eliminate open-market API variance. Our integrated control ensures that every batch contains a completely uniform solid dispersion, delivering a reproducible dissolution rate of ≥ 85% within 45 minutes. For container-scale commercial volumes, this strict process tracking supports a stable manufacturing lead time of 8 to 10 weeks.

Standard spray-layered pellets frequently suffer from high friability. Under the intense mechanical forces of a tableting press, brittle coatings can crack or delaminate from the inert sphere, exposing the amorphous drug phase and causing it to recrystallize into its insoluble form. Our ItraPel-MUPS Premium Grade uses a specialized plasto-elastic polymer binder in the active matrix alongside a microcrystalline cellulose core. This structural combination absorbs compression energies without fracturing, allowing formulators to compress the pellets into high-density MUPS tablets with zero impact on bio-availability profiles. Our production capacity lines maintain a steady, repeatable lead time of 6 to 8 weeks for regular container shipments, providing global manufacturing pipelines with secure inventory continuity.

Navigating international pharmaceutical customs requires strict validation of value-chain trails and full trace-impurity data packages. All our Itraconazole pre-finished formulation campaigns are manufactured under strict GMP conditions. Shipments are fully supported by standard international registration files, including a lot-specific (COA), GHS-compliant (SDS), and comprehensive (TDS). Our advanced analytical testing program includes high-resolution HPLC sweeps for stereoisomeric monitoring and residual solvent mapping, enabling sourcing managers to confidently clear international border inspections and fast-track inner quality-control releases across more than 17 countries.

Basically it varies. Key Packaging Profile: Inert Gas Purged Aluminum Foil Pouches inside Fiber Drums Value Specification: Commercially packed in 10 kg or 25 kg net weight heat-sealed multi-layer aluminum laminate bags. The internal atmosphere is completely purged with ultra-pure Nitrogen (N2) to eliminate ambient oxygen and stop moisture absorption. Pouches are housed inside high-density lever-lock fiber drums certified under international transport criteria.

Store in a secondary climate-controlled facility sealed at ≤ 25° C and ≤ 60% Relative Humidity (RH). Avoid mechanical shearing or high compaction pressures during transfer to preserve the integrity of the outer anti-tack polymer skin.